Pharmacogenomics
Molecular Diagnostics
- Antipsychotic and Antidepressive pharmacogenetics
- Clopidogrel (Plavix®) pharmacogenetics
- Cardiology Panel for pharmacogenetics
- Drug metabolism (CYP2D6, CYP2C9, CYP2C19, CYP3A4 and NAT2 genes)
- Resistance to Imatinib (c-KIT)
- Resistance to Imatinib due to BCR/ABL mutations
- Resistance to Methotrexate (MTHFR)
- Resistance to Methotrexate (SLC19A1) under development
- Susceptibility to Cetuximab (KRAS)
- Susceptibility to Irinotecan (UGT1A1)
- Susceptibility to Sibutramin (GNB3)
- Susceptibility to Warfarin (CYP2C9 and VKORC1)
- Tamoxifen pharmacogenetics
